Supporting Children and Young People to Live Well With Coeliac Disease
Conditions: Celiac Disease; Celiac Disease in Children Intervention: Behavioral: Parent self-help psychological resource Sponsor: University of Surrey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Evaluating ImmuNe Changes in the Evolution of Pre Type 1 Diabetes With Adult ONset
Conditions: Type 1 Diabetes; Type 1 Diabetes Mellitus Maturity Onset Interventions: Genetic: High genetic risk for type 1 diabetes; Genetic: High gentic risk for Coeliac disease Sponsors: Royal Devon and Exeter NHS Foundation Trust; University of Exeter Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Supporting Children and Young People to Live Well With Coeliac Disease
Conditions: Celiac Disease; Celiac Disease in Children Intervention: Behavioral: Parent self-help psychological resource Sponsor: University of Surrey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Evaluating ImmuNe Changes in the Evolution of Pre Type 1 Diabetes With Adult ONset
Conditions: Type 1 Diabetes; Type 1 Diabetes Mellitus Maturity Onset Interventions: Genetic: High genetic risk for type 1 diabetes; Genetic: High gentic risk for Coeliac disease Sponsors: Royal Devon and Exeter NHS Foundation Trust; University of Exeter Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Development of a Celiac Safe Food Additive
Condition: Gluten Intolerance Intervention: Other: Breakfast rolls consisting of wheat flour with and without a E304i/zinc additive Sponsors: Chalmers University of Technology; Gothia Forum - Center for Clinical Trial; Sahlgrenska University Hospital, Sweden Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials